Mesoblast | MSB - Loan Capital


Mesoblast reported $66.02M in Loan Capital for its fiscal semester ending in December of 2025.





Loan Capital Change Date
Avita Medical AUD 42.24M 1.25M Dec/2024
Clinuvel Pharmaceuticals AUD 17.25K 80.1K Dec/2025
Cochlear AUD 200M 6.5M Dec/2025
CSL USD 10.42B 273M Dec/2025
Pacific Edge NZD 126K 425K Jun/2026
Paradigm Biopharmaceuticals AUD 436.81K 336.81K Dec/2025
PYC Therapeutics AUD 436.93K 188.06K Dec/2025
Ramsay Health Care AUD 11.2B 5.74B Dec/2025
Sonic Healthcare AUD 4.19B 333.39M Dec/2024
Starpharma Holdings AUD 1.14M 410K Jun/2025
Telix Pharmaceuticals AUD 564.44M 115.99M Jun/2026